6.7. summary evidence recommendations prognostic factors. summary evidencelein rcc patients, tnm stage, tumour size, grade, rcc subtype provide important prognostic information.2athe 2003 leibovich score validated prognostic model predict short- long-term risk metastasis individual patients sporadic, unilateral pt1-4 n0/+ m0 clear cell renal cell carcinoma.2bthe venuss score validated prognostic model predict short- long-term risk disease recurrence individual patients sporadic, unilateral pt1-4 n0/+ m0 papillary renal cell carcinoma.2b recommendationsstrength ratinguse current tumour, node, metastasis classification system.stronguse who/isup grading system classify renal cell carcinoma type.stronguse prognostic models localised metastatic disease.stronguse 2003 leibovich scoring model risk stratification localised locally advanced clear cell renal cell carcinoma.weakuse venuss scoring model risk stratification localised locally advanced papillary renal cell carcinoma.weakdo routinely use molecular markers assess prognosis.strong table 6.3: prognostic models localised rcc prognostic modelsubtype*risk factors/prognostic factorsuiss** all1. ecog ps2. classification3. n classification (n+ classified metastatic)4. gradet1n0m0g1-2, ecog ps 0: low-risk diseaset3n0m0g2-4, ecog ps ≥ 1 t4n0m0: high-risk diseaseany n0m0: intermediate-risk diseaseleibovich score/model 2003 cc1. classification (pt1a: 0, pt1b: 1, pt2:3, pt3-4: 4 points)2. n classification (pnx/n0: 0, pn+: 2 points)3. tumour size (< 10 cm: 0, ≥ 10 cm: 1 point)4. grade (g1-2: 0, g3: 1, g4: 3 points)5. tumour necrosis (absent: 0, present: 1 point)0-2 points: low-risk disease3-5 points: intermediate-risk disease6 points: high-risk diseaseleibovich score/model 2018 cc, p, chccrccprogression (9 factors): constitutional symptoms, grade, tumour necrosis, sarcomatoid features, tumour size, perinephric sinus fat invasion, tumour thrombus level, extension beyond kidney, nodal involvement.cancer-specific survival (12 factors): age, ecog ps, constitutional symptoms, adrenalectomy, surgical margins, grade, tumour necrosis, sarcomatoid features, tumour size, perinephric sinus fat invasion, tumour thrombus, nodal involvement.no risk groups /prognostic groups.prcclow risk (group 1): grade 1-2, fat invasion, tumour thrombus.intermediate risk (group 2): grade 3, fat invasion, tumour thrombus.high risk (group 3): grade 4 fat invasion level tumour thrombus.chrcclow risk (group 1): fat invasion, sarcomatoid differentiation, nodal involvement.intermediate risk (group 2): fat invasion sarcomatoid differentiation nodal involvement.high risk (group 3): sarcomatoid differentiation nodal involvement.venuss score/model*** p1. classification (pt1: 0, pt2: 1, pt3-4: 2 points)2. n classification (pnx/pn0: 0, pn1: 3 points)3. tumour size (≤ 4 cm: 0, > 4 cm: 2 points)4. grade (g1/2: 0, g3/4: 2 points)5. tumour thrombus (absent: 0, present: 2 points)0-2 points: low-risk disease3-5 points: intermediate-risk disease6 points: high-risk diseasegrant score/model**** all1. age > 60 years2. classification = t3b, pt3c pt43. n classification = pn14. (fuhrman) grade = g3 g40-1 factors: favourable-risk disease2 factors: unfavourable-risk disease * ccrcc = clear-cell rcc; ecog = eastern cooperative oncology group; prcc = papillary rcc; chrcc = chromophobe rcc; ps = performance status.** university california integrated staging system. available https://www.mdcalc.com/ucla-integratedstaging-system-uiss-renal-cell-carcinoma-rcc.*** venous extension, nuclear grade, size, stage. available https://www.evidencio.com/models/show/2369.**** grade, age, nodes tumour. table 6.4: prognostic models metastatic rcc prognostic modelsubtyperisk factors/prognostic factorsmskcc **all1. karnofsky ps * < 80%2. interval diagnosis systemic treatment < 1 year3. haemoglobin < lower limit normal4. corrected calcium >10mg/dl/> 2.5 mmol/l5. ldh > 1.5x upper limit normal0 factors: favourable-risk disease1-2 factors: intermediate-risk disease3-5 factors: poor-risk diseaseimdc ***all1. karnofsky ps * < 80%2. interval diagnosis treatment < 1 year3. haemoglobin < lower limit normal4. corrected calcium > upper limit normal (i.e. > 10.2 mg/dl)5. neutrophil count > upper limit normal (i.e. > 7.0×10⁹/l)6. platelet count > upper limit normal (i.e. > 400,000)0 factors: favourable-risk disease1-2 factors: intermediate-risk disease3-6 factors: poor-risk disease imdc = international metastatic renal cancer database consortium; ldh = lactate dehydrogenase;mskcc = memorial sloan kettering cancer center; ps = performance status.* karnofsky performance status calculator: https://www.thecalculator.co/health/karnofsky-score-for-performance-status-calculator-961.html.** mskcc: https://www.mdcalc.com/memorial-sloan-kettering-cancer-center-mskcc-motzer-score-etastaticrenal-cell-carcinoma-rcc.*** imdc: https://www.mdcalc.com/imdc-international-metastatic-rcc-database-consortium-risk-score-rcc.